Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.
Ogino H, Taylor JW, Nejo T, Gibson D, Watchmaker PB, Okada K, Saijo A, Tedesco MR, Shai A, Wong CM, Rabbitt JE, Olin MR, Moertel CL, Nishioka Y, Salazar AM, Molinaro AM, Phillips JJ, Butowski NA, Clarke JL, Oberheim Bush NA, Hervey-Jumper SL, Theodosopoulos P, Chang SM, Berger MS, Okada H. Ogino H, et al. Among authors: theodosopoulos p. J Clin Invest. 2022 Feb 1;132(3):e151239. doi: 10.1172/JCI151239. J Clin Invest. 2022. PMID: 34882581 Free PMC article. Clinical Trial.
Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty.
Salans M, Ni L, Morin O, Ziemer B, Capaldi DPI, Raleigh DR, Vasudevan HN, Chew J, Nakamura J, Sneed PK, Boreta L, Villanueva-Meyer JE, Theodosopoulos P, Braunstein S. Salans M, et al. Among authors: theodosopoulos p. J Neurooncol. 2024 Feb;166(3):535-546. doi: 10.1007/s11060-024-04578-6. Epub 2024 Feb 5. J Neurooncol. 2024. PMID: 38316705 Free PMC article.
International Tuberculum Sellae Meningioma Study: Surgical Outcomes and Management Trends.
Magill ST, Schwartz TH, Couldwell WT, Gardner PA, Heilman CB, Sen C, Akagami R, Cappabianca P, Prevedello DM, McDermott MW; International Tuberculum Sellae Meningioma Study Authors. Magill ST, et al. Neurosurgery. 2023 Dec 1;93(6):1259-1270. doi: 10.1227/neu.0000000000002569. Epub 2023 Jun 30. Neurosurgery. 2023. PMID: 37389475
International Tuberculum Sellae Meningioma Study: Preoperative Grading Scale to Predict Outcomes and Propensity-Matched Outcomes by Endonasal Versus Transcranial Approach.
Magill ST, Schwartz TH, Couldwell WT, Gardner PA, Heilman CB, Sen C, Akagami R, Cappabianca P, Prevedello DM, McDermott MW; International Tuberculum Sellae Meningioma Study. Magill ST, et al. Neurosurgery. 2023 Dec 1;93(6):1271-1284. doi: 10.1227/neu.0000000000002581. Epub 2023 Jul 7. Neurosurgery. 2023. PMID: 37418417
Treated large posterior fossa vestibular schwannoma and meningioma: Hearing outcome and willingness-to-accept brain implant for unilateral deafness.
Jiam NT, Gillard DM, Morshed RA, Bhutada AS, Crawford ED, Braunstein SW, Henderson Sabes J, Theodosopoulos PV, Cheung SW. Jiam NT, et al. Laryngoscope Investig Otolaryngol. 2022 Oct 27;7(6):2057-2063. doi: 10.1002/lio2.957. eCollection 2022 Dec. Laryngoscope Investig Otolaryngol. 2022. PMID: 36544942 Free PMC article.
Temozolomide in the treatment of recurrent malignant glioma.
Chang SM, Theodosopoulos P, Lamborn K, Malec M, Rabbitt J, Page M, Prados MD. Chang SM, et al. Among authors: theodosopoulos p. Cancer. 2004 Feb 1;100(3):605-11. doi: 10.1002/cncr.11949. Cancer. 2004. PMID: 14745879 Free article. Clinical Trial.
Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
Han SJ, Reis G, Kohanbash G, Shrivastav S, Magill ST, Molinaro AM, McDermott MW, Theodosopoulos PV, Aghi MK, Berger MS, Butowski NA, Barani I, Phillips JJ, Perry A, Okada H. Han SJ, et al. J Neurooncol. 2016 Dec;130(3):543-552. doi: 10.1007/s11060-016-2256-0. Epub 2016 Sep 13. J Neurooncol. 2016. PMID: 27624915 Free PMC article.
169 results